01.07.2004 | Report
Identification of HER2/neu-Derived Peptides Capable of Inducing both Cellular and Humoral Immune Responses in HLA-A24 Positive Breast Cancer Patients
Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2004
Einloggen, um Zugang zu erhalten